Biocryst Pharmaceuticals (BCRX) Return on Invested Capital (2023 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Return on Invested Capital came in at 0.3% in Q1 2026, down 32.0% YoY from 0.44% in Q1 2025, and down 227.37% on a QoQ basis from 0.24% in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Return on Invested Capital (2023 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 4 years of Return on Invested Capital data on file, last reported at 0.3% in Q1 2026.
- Quarterly Return on Invested Capital fell 32.0% year-over-year to 0.3% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.3% (down 32.0% YoY) and the FY2025 annual result came in at 1.0%, up 101.0% from the prior year.
- Return on Invested Capital retreated to 0.3% in Q1 2026, from 0.24% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.24% in Q4 2025 to a low of 0.49% in Q1 2023.
- A 4-year average of 0.14% and a median of 0.06% in 2024 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2024 — Return on Invested Capital soared 38 bps — and 2026, when it sank 32 bps.
- Tracing BCRX's Return on Invested Capital over 4 years: stood at 0.29% in 2023, then surged by 99 bps to 0.0% in 2024, then surged by 14636 bps to 0.24% in 2025, then tumbled by 227 bps to 0.3% in 2026.
- The last three Return on Invested Capital figures came in at 0.3% (Q1 2026), 0.24% (Q4 2025), and 0.07% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | -0.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.28% |
| Mar 31, 2026 | -0.30% |
| Dec 31, 2025 | 0.24% |
| Sep 30, 2025 | 0.07% |
| Jun 30, 2025 | 0.04% |
| Mar 31, 2025 | 0.02% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -0.03% |
| Jun 30, 2024 | -0.06% |
| Mar 31, 2024 | -0.14% |
| Dec 31, 2023 | -0.29% |
| Sep 30, 2023 | -0.41% |
| Jun 30, 2023 | -0.43% |
| Mar 31, 2023 | -0.49% |